Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials. (Q50862894)
Jump to navigation
Jump to search
scientific article published on 3 April 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials. |
scientific article published on 3 April 2017 |
Statements
1 reference
Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials. (English)
1 reference
M V Dieci
A Frassoldati
D Generali
G Bisagni
F Piacentini
L Cavanna
K Cagossi
A Michelotti
R Berardi
G Banna
A Goubar
3 April 2017
1 reference